Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23135382)

1.

Intentional low-molecular-weight heparin overdose: a case report and review.

Byrne M, Zumberg M.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):772-4. doi: 10.1097/MBC.0b013e328358e8af.

PMID:
23135382
2.
3.

Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients.

Lin H, Faraklas I, Saffle J, Cochran A.

J Trauma. 2011 Dec;71(6):1557-61. doi: 10.1097/TA.0b013e31823070f9.

PMID:
22027887
4.

Protamine reversal of low molecular weight heparin: clinically effective?

van Veen JJ, Maclean RM, Hampton KK, Laidlaw S, Kitchen S, Toth P, Makris M.

Blood Coagul Fibrinolysis. 2011 Oct;22(7):565-70. doi: 10.1097/MBC.0b013e3283494b3c.

PMID:
21959588
5.

Intentional overdose with tinzaparin: management dilemmas.

Balla I, Karafotias I, Christopoulos C.

J Emerg Med. 2014 Feb;46(2):197-201. doi: 10.1016/j.jemermed.2013.08.030. Epub 2013 Sep 29.

PMID:
24084058
6.

Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5?

Yildirim T, Kocak T, Buyukasik Y, Yilmaz R, Altun B, Erdem Y, Arici M.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):700-4. doi: 10.1097/MBC.0b013e328356717f.

PMID:
23135378
8.

Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.

Brophy DF, Martin EJ, Gehr TW, Carr ME Jr.

Am J Kidney Dis. 2004 Aug;44(2):270-7.

PMID:
15264185
9.

Use of recombinant factor VIIa (NovoSeven(®)) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux.

Luporsi P, Chopard R, Janin S, Racadot E, Bernard Y, Ecarnot F, Séronde MF, Briand F, Guignier A, Descotes-Genon V, Meneveau N, Schiele F.

Acute Card Care. 2011 Jun;13(2):93-8. doi: 10.3109/17482941.2011.567281. Epub 2011 Apr 25.

PMID:
21517672
10.

Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.

Gatt A, van Veen JJ, Woolley AM, Kitchen S, Cooper P, Makris M.

Thromb Haemost. 2008 Aug;100(2):350-5.

PMID:
18690358
11.

Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.

Ludwig KP, Simons HJ, Mone M, Barton RG, Kimball EJ.

Ann Pharmacother. 2011 Nov;45(11):1356-62. doi: 10.1345/aph.1Q313. Epub 2011 Oct 18.

PMID:
22009998
12.

Managing bleeding complications in patients treated with the old and the new anticoagulants.

Romualdi E, Rancan E, Siragusa S, Ageno W.

Curr Pharm Des. 2010;16(31):3478-82. Review.

PMID:
20858186
13.

Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.

Renda G, Di Pillo R, D'Alleva A, Sciartilli A, Zimarino M, De Candia E, Landolfi R, Di Giammarco G, Calafiore A, De Caterina R.

Haematologica. 2007 Mar;92(3):366-73.

14.

Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.

Vavra KA, Lutz MF, Smythe MA.

Ann Pharmacother. 2010 Apr;44(4):718-26. doi: 10.1345/aph.1M447. Epub 2010 Mar 16. Review.

PMID:
20233918
15.

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Pediatr Hematol Oncol. 2008 Jun;25(4):301-11. doi: 10.1080/08880010802016904.

PMID:
18484474
16.

[The risk of bleeding associated with low molecular weight heparin in patients with renal failure].

Lai S, Barbano B, Cianci R, Gigante A, Di Donato D, Asllanaj B, Dimko M, Mariotti A, Morabito S, Pugliese F.

G Ital Nefrol. 2010 Nov-Dec;27(6):649-54. Italian.

PMID:
21132647
17.

Comparative pharmacodynamic time-course of bemiparin and enoxaparin in healthy volunteers.

Antonijoan RM, Rico S, Martínez-González J, Borrell M, Valcarcel D, Fontcuberta J, Barbanoj MJ.

Int J Clin Pharmacol Ther. 2009 Dec;47(12):726-32.

PMID:
19954711
18.

Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series.

Deal EN, Hollands JM, Riney JN, Skrupky LP, Smith JR, Reichley RM.

J Thromb Thrombolysis. 2011 Aug;32(2):188-94. doi: 10.1007/s11239-011-0584-7.

PMID:
21465129
19.

Controversies of anticoagulation reversal in life-threatening bleeds.

Rolfe S, Papadopoulos S, Cabral KP.

J Pharm Pract. 2010 Jun;23(3):217-25. doi: 10.1177/0897190010362168. Epub 2010 Apr 13. Review.

PMID:
21507817
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk